Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

NMR vs SMFG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SMFG Captures Overall Composite Edge (59.1 HOLD vs 44.5 HOLD), While NMR Leads 3–2 on Growth & Valuation Pillars

SMFG Overall Winner 6-Pillar Tally: NMR 3 – 2 SMFG (1 Tie) Matrix Metrics: NMR 5 – 5 SMFG

As of Nov 17, 2026, Sumitomo Mitsui Financial Group, Inc (SMFG) captures the overall head-to-head institutional edge over Nomura Holdings, Inc (NMR) on higher Unified Composite conviction (59.1/100 HOLD vs. 44.5/100 HOLD) after splitting the core matrix 5–5 (led by Profitability & Quality, R&D & Supply-Chain Moat), while NMR wins 3–2 across the 6-pillar growth and valuation breakdown. NMR trades at $9.34 (12.7x Forward P/E, 25.1% operating margin) versus SMFG at $23.34 (13.8x Forward P/E, 32.1% operating margin).

  • Growth vs. Quality Trade-Off: SMFG earns the overall head-to-head edge with a stronger Unified Composite Score (59.1/100 HOLD vs. NMR 44.5/100 HOLD) and 1.17β · 34% Vol risk profile, whereas NMR leads top-line expansion (+17.9% YoY revenue growth, 0.81x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5); meanwhile SMFG is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NMR vs SMFG
NMR NYSE
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$9.34
-1.74% 1D
Market Cap $28.3B
TTM Revenue $14.9B
Forward P/E 12.7x
Beta / 30D Vol 1.03β · 29% Vol
Unified Composite Score
44.5 / 100 HOLD
Tech 47.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.5 · SMA20: $9.40 · SMA50: $9.68
SMFG NYSE Head-to-Head Winner
Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 3/5th of a share of common stock)
Commercial Banks, Nec
$23.34
-3.45% 1D
Market Cap $156.3B
TTM Revenue $40.1B
Forward P/E 13.8x
Beta / 30D Vol 1.17β · 34% Vol
Unified Composite Score
59.1 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 58.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.7%), weak momentum, RSI 40
RSI-14: 40.4 · SMA20: $24.14 · SMA50: $25.13

6-Pillar Scorecard Institutional Category Breakdown (NMR 3 – 2 SMFG)

Columns: Metric · NMR · SMFG
1. Valuation Multiples NMR
Forward P/E 12.7x 13.8x
Trailing P/E 11.2x 15.0x
PEG Ratio 0.81x 2.02x
EV / Revenue 1.9x 3.9x
2. Growth & Scale NMR
Revenue Growth (YoY) +17.9% +7.5%
Earnings Growth (YoY) +13.6% -8.5%
TTM Revenue (USD) $14.9B $40.1B
Market Cap $28.3B $156.3B
3. Profitability & Quality SMFG
Gross Margin 77.4% 100.0%
Operating Margin 25.1% 32.1%
Net Profit Margin 17.1% 26.0%
Return on Equity (ROE) 11.5% 8.1%
4. Balance Sheet & Cash Flow NMR
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $8.17 Book/Sh · 11.5% ROE $13.13 Book/Sh · 8.1% ROE
Dividend Yield 3.34% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 30.7% (<1st %ile) 27.8% (23rd %ile)
Put/Call OI Skew Thin ADR Chain Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat SMFG
OpEx & R&D Intensity 52.3% of Rev ($7.77B) 67.9% of Rev ($27.2B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat High-Margin Pricing Power Moat
Supply-Chain Role Capital Markets Operator Banks - Diversified Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NMR (5) vs SMFG (5)
Institutional Metric NMR SMFG Criterion Row Edge
Market Capitalization
Scale
$28.3B $156.3B Larger Scale SMFG
Trailing P/E Ratio
Valuation
11.2x 15.0x Lower Multiple NMR
Forward P/E Ratio
Valuation
12.7x 13.8x Lower Multiple NMR
Revenue Growth (YoY)
Growth
+17.9% +7.5% Higher Growth NMR
Operating Margin (TTM)
Profitability
25.1% 32.1% Higher Margin SMFG
Net Profit Margin
Profitability
17.1% 26.0% Higher Margin SMFG
Return on Equity (ROE)
Capital Efficiency
11.5% 8.1% Higher ROE NMR
52-Week Range Position
Momentum
60% ($7–$11) 62% ($17–$28) Stronger Trend SMFG
Beta / 30D Volatility
Risk Regime
1.03β · 29% Vol 1.17β · 34% Vol Lower Realized Risk NMR
Unified Institutional Score
Composite Signal
44.5 / 100 (HOLD) 59.1 / 100 (HOLD) Higher Composite SMFG
Trailing 12M Revenue (USD)
Operating Scale
$14.9B $40.1B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
77.4% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.81x PEG · 1.9x EV/Rev 2.02x PEG · 3.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($8.17 Book/Sh · 11.5% ROE) N/A ($13.13 Book/Sh · 8.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NMR +6.72 pp
NMR: +2.36% · SMFG: -4.36%
3M Horizon NMR +3.15 pp
NMR: -1.84% · SMFG: -4.99%
6M Horizon NMR +12.42 pp
NMR: +16.69% · SMFG: +4.27%
1Y Horizon SMFG +7.23 pp
NMR: +26.32% · SMFG: +33.55%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs SMFG. Trailing 12-month operating profitability (NMR 25.1% vs SMFG 32.1%) and valuation multiples (NMR 12.7x vs SMFG 13.8x Forward P/E) are benchmarked directly in Pillar 4 below.

NMR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$14.9B
Gross Margin77.4%
Op. Margin25.1%
ROE / Fwd P/E11.5% · 12.7x
SMFG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$40.1B
Gross Margin100.0%
Op. Margin32.1%
ROE / Fwd P/E8.1% · 13.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NMR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 30.7%
IV Percentile <1st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NMR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SMFG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 27.8%
IV Percentile 23rd %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SMFG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NMR Moat Profile Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $28.3B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment 52.3% of Rev ($7.77B)
90D Engineering Disclosures 0 Published
SMFG Moat Profile High-Margin Pricing Power Moat
Banks - Diversified Operator
Competes within the Banks - Diversified value chain with $156.3B market capitalization and 32.1% operating margin.
OpEx & R&D Reinvestment 67.9% of Rev ($27.2B)
90D Engineering Disclosures 0 Published

Investor FAQ NMR vs SMFG Key Questions & Quantitative Answers

As of Nov 17, 2026, Sumitomo Mitsui Financial Group, Inc (SMFG) captures the overall head-to-head institutional edge over Nomura Holdings, Inc (NMR) on higher Unified Composite conviction (59.1/100 HOLD vs. 44.5/100 HOLD) after splitting the core matrix 5–5 (led by Profitability & Quality, R&D & Supply-Chain Moat), while NMR wins 3–2 across the 6-pillar growth and valuation breakdown. NMR trades at $9.34 (12.7x Forward P/E, 25.1% operating margin) versus SMFG at $23.34 (13.8x Forward P/E, 32.1% operating margin). Growth vs. Quality Trade-Off: SMFG earns the overall head-to-head edge with a stronger Unified Composite Score (59.1/100 HOLD vs. NMR 44.5/100 HOLD) and 1.17β · 34% Vol risk profile, whereas NMR leads top-line expansion (+17.9% YoY revenue growth, 0.81x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5); meanwhile SMFG is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NMR leads the Growth & Scale pillar: NMR posts +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin), compared with SMFG at +7.5% YoY revenue growth and -8.5% YoY earnings growth on $40.1B TTM revenue (100.0% gross margin, 32.1% operating margin). On trailing 12-month operating scale, NMR generates $14.9B in USD-normalized revenue versus $40.1B for SMFG. In operating R&D and SG&A reinvestment, NMR deploys 52.3% of Rev ($7.77B) (0 90-day corporate R&D disclosures) versus 67.9% of Rev ($27.2B) (0 disclosures) for SMFG.

NMR screens cheaper on headline valuation multiples. NMR trades at 12.7x Forward P/E, 11.2x Trailing P/E, 0.81x PEG, and 1.9x EV/Revenue (unreported cash flow margin), whereas SMFG trades at 13.8x Forward P/E, 15.0x Trailing P/E, 2.02x PEG, and 3.9x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NMR (11.5% ROE) versus SMFG (8.1% ROE) capital efficiency.

In options market volatility and institutional positioning, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 29% Vol realized risk). By comparison, SMFG carries 27.8% implied volatility (23rd %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.17β · 34% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 3/5th of a share of common stock) (SMFG) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.